Atrys Health, S.A. Stock: price and insider trades · Spain

This page follows insider dealings at Atrys Health, S.A. as filed with CNMV, a company from the Healthcare & Pharma sector based in Madrid, Spain. Over the twelve months to 18 October 2026, the company's managers filed 8 filings, from 7 insiders.

Purchases and sales both appear in the filings: 5 purchases (4 insiders, €453k) and 1 sale (1 insider, €11k). Taken together, the purchases exceed the sales by €442k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 3 chief executives and 1 board member among the declarants. The largest single trade was a purchase of €306k by Inveready Evergreen S.C.R. S.A., published on 20 November 2025, equal to 0.15% of the market capitalisation.

In the case of 2 purchases, another manager of the company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last insider purchase was made public on 9 July 2026, 101 days ago. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19).

With 8 filings in twelve months, the company is more active than the median of 7 filings across the 102 companies we follow on the same exchange. The full history, which starts in 2022, counts 60 purchases against 13 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. Source: insider filings from CNMV. Past trades are no guide to future returns.